Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09AWM
|
|||
| Former ID |
DIB004397
|
|||
| Drug Name |
ODSH
|
|||
| Synonyms |
Cardiac ischemia reperfusion injury therapy, ParinGenix; ODSH (iv); PGX-100; PGX-200; ODSH (inhaled formulation), ParinGenix; ODSH (iv), ParinGenix; 2-O, 3-O desulfated heparin (inhaled), ParinGenix; 2-O, 3-O heparin (intravenous formulation), ParinGenix
Click to Show/Hide
|
|||
| Indication | Chronic obstructive pulmonary disease [ICD-11: CA22; ICD-10: J44, J44.9] | Phase 2 | [1] | |
| Company |
ParinGenix Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022098) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.